Home
>
National Drug Code (NDC)
>
Motion Sickness
Motion Sickness - 15127-262-12 - (Dimenhydrinate)
Drug Information of Motion Sickness
| Product NDC: | 15127-262 |
| Proprietary Name: | Motion Sickness |
| Non Proprietary Name: | Dimenhydrinate |
| Active Ingredient(s): | 50 mg/1 & nbsp; Dimenhydrinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Motion Sickness
| Product NDC: | 15127-262 |
| Labeler Name: | Stephen L. LaFrance Pharmacy, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part336 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 19921201 |
Package Information of Motion Sickness
| Package NDC: | 15127-262-12 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (15127-262-12) > 12 TABLET in 1 BLISTER PACK |
NDC Information of Motion Sickness
| NDC Code | 15127-262-12 |
| Proprietary Name | Motion Sickness |
| Package Description | 1 BLISTER PACK in 1 CARTON (15127-262-12) > 12 TABLET in 1 BLISTER PACK |
| Product NDC | 15127-262 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Dimenhydrinate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19921201 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Stephen L. LaFrance Pharmacy, Inc. |
| Substance Name | DIMENHYDRINATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
